Vascular dilation and tortuosity in plus disease

Archives of Ophthalmology

Volumn 127, Issue 1, 2009, Pages 112-113

  Yanovitch, Tammy L ^b   Freedman, Sharon F ^b   Wallace, David K ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CONTROLLED STUDY; EYE EXAMINATION; HUMAN; IMAGE ANALYSIS; INFANT; LETTER; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PLUS DISEASE; PRIORITY JOURNAL; RETINA DISEASE; SENSITIVITY AND SPECIFICITY; VASODILATATION;

DILATATION, PATHOLOGIC; HUMANS; INFANT, NEWBORN; PHOTOGRAPHY; RETINAL VESSELS; RETINOPATHY OF PREMATURITY;

EID: 58449097953     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2008.527     Document Type: Letter

References (5)

1. Good WV; Early Treatment for Retinopathy of Prematurity Cooperative Group. Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial. Trans Am Ophthalmol Soc. 2004;102:233-250.
2. Kylstra JA, Freedman SF, Capowski JJ, Hall JG. Measurement of retinal vessel tortuosity as a means of diagnosing plus disease in ROP [abstract]. Invest Ophthalmol Vis Sci. 1995;36(4):S18.
3. Wallace DK, Freedman SF, Zhao Z, Jung SH. Accuracy of ROPtool vs individual examiners in assessing retinal vascular tortuosity. Arch Ophthalmol. 2007;125(11):1523-1530.
4. Koreen S, Gelman R, Martinez-Perez M, et al. Evaluation of a computerbased system for plus disease diagnosis in retinopathy of prematurity. Ophthalmology. 2007;114(12):e59-e67.
5. STOP-ROP Multicenter Study Group. Supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP): a randomized, controlled trial, I: primary outcomes. Pediatrics. 2000;105(2):295-310.